Partner with Caelus Health to solve their R&D challenges
06-10-2022
X
Watch the webinar
Enter your details below to access the audio and video recording of this event, and to receive updates about future virtual events.
If you’re already subscribed to IN-PART, please enter your details and you’ll be taken to the recordings.
By registering to attend you agree to receive emails about our virtual events. You can unsubscribe at any time through these emails. Information about how we store and process data in compliance with GDPR is outlined in our privacy policy.
In the first event of our latest Virtual Series, we spoke with Luc Sterkman, CEO at Caelus Health– who has an extensive track record in the life sciences industry, including senior management positions in biotech, food and pharma industries. We heard about their R&D priorities and the research they’re looking for from academia.
What’s covered in this event?
- 00:00 – Introduction to the event from IN-PART
- 04:02 – Introduction to Caelus Health
- 07:20 – Overview of Caelus’s current work
- 08:46 – Lead Discovery and development approach
- 10:45 – Overview of lead compound E. hallii
- 16:27 – R&D priorities and academic partnering opportunities
- 19:07 – Live Q&A
- 36:50 – Closing remarks
Format: Presentation followed by live Q&A (~40 minutes)
As part of our current Global Challenge campaign on the human microbiome, Caelus Health have shared their interests through this webinar and in a one-page summary (company interests and priorities), with the view to identify new academic partners for collaboration and commercialisation partnerships.
About Caelus Health: Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialisation of microbiota-based products to prevent and treat cardiometabolic disorders, including diabetes, and other unmet medical needs.
More Information:
There are over 10 times as many microbial cells in the human body as there are human cells. These cells make up the human microbiome, communities of microbes, including bacteria and fungi that have greater complexity than the human genome itself. The microbiome can found in multiple sites across the human body for example, the gut, skin, and oral and nasal cavities which all have a different community of microbes.
As the key interface between the body and the environment, the human microbiome has extensive functions to protect us against pathogens, develop immunity, and aid digestion and metabolism.
In the first event of our Virtual Series, running alongside our latest Global Challenges campaign, we’ll be speaking with external innovation and R&D leads at a number of companies in the microbiome space to hear about the roadblocks they face, and the priority research they’re looking for from academia to support their product and R&D pipelines.
Some of the topics covered will include:
- The top priorities and technical challenges for each company
- What research solutions companies are actively searching for from academia
- The companies’ preferred approaches to partnering with academic research and expertise
Who should attend?
- Technology transfer, research commercialisation + industry engagement teams
- Academic researchers
- Industry R&D and open/external innovation teams
Run in partnership with:
ASTP are Europe’s premier association of knowledge transfer professionals whose work aims to improve the quality of impact that public research has on the economy and society. Learn more.
PraxisAuril are a world-leading professional association for knowledge exchange practitioners, whose network includes 5000+ KE professionals. Learn more.
What is IN-PART?
IN-PART develops digital solutions, curated by in-house STEM experts, that simplify the initial connection between decision-makers in academia and industry. Our goal is to help drive impact from research by matching innovation and expertise on a level playing field globally.
Connect, a digital partnering platform for university-industry collaboration.
An online matchmaking platform used by 250+ universities and research institutes to connect with industry teams in 6,000+ companies to commercialise academic innovations and expertise that are available and seeking collaboration.
Discover, a bespoke scouting service for open innovation.
A bespoke scouting platform used by innovation-driven companies to profile the global landscape of academia across an active network of 2,400+ institutes, either through ‘Industry Calls for Opportunities’ or ‘Request for Proposal’ campaigns that find and confirm potential solutions to specific R&D challenges or requirements.